PAEDIATRICS

Curriculum

23 Sections
47 Lessons
10 Weeks

Expand all sectionsCollapse all sections

SCARLET FEVER
5
- 1.1
  DEFINITION, PREVALENCE & RISK FACTORS
- 1.2
  SIGNS & SYMPTOMS
- 1.3
  INVESTIGATIONS & DIAGNOSIS
- 1.4
  TREATMENT PLAN & PROGNOSIS
- 1.5
  COMPLICATIONS & KEY INFORMATION
MEASLES
3
- 2.1
  DEFINITION, RISK FACTORS & SIGNS & SYMPTOMS
- 2.2
  INVESTIGATIONS & DIAGNOSIS & TREATMENT PLAN
- 2.3
  COMPLICATIONS & KEY INFORMATION
MUMPS
4
- 3.1
  DEFINITION, PREVALENCE & ETIOLOGY
- 3.2
  RISK FACTORS, SIGNS & SYMPTOMS
- 3.3
  INVESTIGATIONS & DIAGNOSIS, TREATMENT PLAN
- 3.4
  PROGNOSIS, KEY INFORMATION & EXTRA’S
VIRAL DISEASE DURATIONS
1
- 4.1
  KEY INFORMATION
NAPPY RASH
3
- 5.1
  DEFINITION, ETIOLOGY & RISK FACTORS
- 5.2
  SIGNS & SYMPTOMS, INVESTIGATIONS & DIAGNOSIS, TREATMENT PLAN
- 5.3
  PROGNOSIS & EXTRA’S
MENINGITIS
3
- 6.1
  DEFINITION, PREVALENCE, ETIOLOGY & RISK FACTORS
- 6.2
  SIGNS & SYMPTOMS, TREATMENT PLAN
- 6.3
  COMPLICATIONS & KEY INFORMATION
FAILURE TO THRIVE
3
- 7.1
  DEFINITION, PREVALENCE & ETIOLOGY
- 7.2
  RISK FACTORS & SUSPECTED IF
- 7.3
  DIAGNOSIS, TREATMENT PLAN & COMPLICATIONS
FEVERISH CHILDREN
2
- 8.1
  DEFINITION & RISK FACTORS
- 8.2
  SIGNS & SYMPTOMS
AUTISM IN CHILDREN
Autism is a type of childhood diagnosis characterised by restrictive behaviours, meaning restricted interests and rigid behaviours with a lifelong impact. It affects patients socially, physically, occupationally, and educationally. As a spectrum disorder, there are different degrees of the condition. Aetiology: - Unknown
1
- 9.1
  Risk Factors
ACUTE CHILDHOOD LIMP
3
- 10.1
  DEFINITION, PREVALENCE & ETIOLOGY
- 10.2
  SIGNS & SYMPTOMS, INVESTIGATIONS & DIAGNOSIS
- 10.3
  TREATMENT PLAN, PROGNOSIS, KEY INFORMATION & EXTRA’S
DEVELOPMENT OF RHEUMATOLOGY IN CHILDREN
3
- 11.1
  DEFINITION, PREVALENCE & ETIOLOGY
- 11.2
  RISK FACTORS, SIGNS & SYMPTOMS
- 11.3
  INVESTIGATIONS & DIAGNOSIS, TREATMENT PLAN, PROGNOSIS & KEY INFORMATION
NEWBORN BLOOD SPOT TESTING
1
- 12.1
  DEFINITION, ETIOLOGY & INVESTIGATIONS
HEARING TEST IN NEWBORNS
1
- 13.1
  DEFINITION
PERSONAL & SOCIAL DEVELOPMENT
1
- 14.1
  DEFINITION, PREVALENCE, DEVELOPMENT BY AGE & TREATMENT PLAN
FINE MOTOR DEVELOPMENT
1
- 15.1
  DEFINITION, DEVELOPMENT BY AGE
GROSS MOTOR DEVELOPMENT
1
- 16.1
  DEFINITION & KEY INFORMATION
LANGUAGE DEVELOPMENT
1
- 17.1
  DEFINITION , EXPRESSIVE LANGUAGE DEVELOPMENT, RECEPTIVE LANGUAGE DEVELOPMENT
BIRTH TRAUMA’S
1
- 18.1
  Traumas
GENETIC DISORDERS
3
- 19.1
  STRUCTURAL CHROMOSOMAL SYNDROMES
- 19.2
  TUBEROUS SCLEROSIS, METABOLIC CONDITIONS & NEONATAL BLOOD SPOT SCREENING
- 19.3
  INHERITED METABOLIC CONDITIONS
CONGENITAL HEART DISEASES
3
- 20.1
  DEFINITION, PREVALENCE & ETIOLOGY
- 20.2
  RISK FACTORS, SIGNS & SYMPTOMS & INVESTIGATIONS & DIAGNOSIS
- 20.3
  TREATMENT PLAN, PROGNOSIS, KEY INFORMATION & EXTRA’S
INTUSSUSCEPTION
2
- 21.1
  DEFINITION, PREVALENCE, ETIOLOGY, RISK FACTORS
- 21.2
  SIGNS & SYMPTOMS, INVESTIGATIONS & DIAGNOSIS, TREATMENT PLAN, PROGNOSIS
GUT ATRESIA, HERNIAS, EXOMPHALOS & GASTROSCHISIS
1
- 22.1
  PAEDIATRIC SURGICAL CONDITIONS
Flash Card
0

INHERITED METABOLIC CONDITIONS

INHERITED METABOLIC CONDITIONS

Phenylketonuria
Unable to break down phenylalanine
Developmental delay, learning difficulties, seizures
MCADD
Impaired fat metabolism
High C8 carnitine levels
Glutaric acidaemia type 1
Poor growth, hypotonia
Dystonia, developmental delay
Brain damage
Metabolic crisis risk <1 year
Maple syrup urine disease
Enzyme defects affecting leucine, valine, isoleucine
Normal at birth
Maple syrup odour
Metabolic crisis <1 week
Homocystinuria
High blood/urine homocysteine
Short stature, hyperlaxity, pectus excavatum
Osteoporosis
Lens dislocation
Learning disability
Stroke risk
Psychiatric disorders
Isovaleric acidaemia
Acute form: presents days/weeks, distinctive odour, poor feeding, weight loss Mild form: periodic severe ketosis.